Back to company

NOVARTIS HEALTHCARE A/S: Financial statements 2021

CVR: 20575786

NOVARTIS HEALTHCARE A/S (CVR 20575786) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 701,904,000 and a net result of DKK 84,886,000 compared with DKK 127,706,767 the year before. That is a decrease of 30% compared with the year before. The profit margin was 12.1%. Equity amounted to DKK 233,759,000. The solvency ratio was 24.8%. The company had 125 employees in the financial year.

Revenue
701,904,000 kr.
Gross Profit
170,533,000 kr.
Profit/Loss
84,886,000 kr.
Equity
233,759,000 kr.
Total Assets
943,865,000 kr.
Employees
125

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021701.9 mio.170.5 mio.84.9 mio.233.8 mio.125
20201 mia.196.8 mio.127.7 mio.148.9 mio.131
2019966.6 mio.170.6 mio.-98.6 mio.21.2 mio.126
2018867.8 mio.168.9 mio.83.2 mio.119.7 mio.107
2017731.8 mio.188 mio.29.4 mio.186.5 mio.113

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like NOVARTIS HEALTHCARE A/S

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

NOVARTIS HEALTHCARE A/S: The 2020 annual report is outJun 16, 2021

NOVARTIS HEALTHCARE A/S has published its annual report for 2020. Revenue came to DKK 1,002,386,267, and the net result was DKK 127,706,767.

Peter Drøidal joins NOVARTIS HEALTHCARE A/S as adm. dir.Feb 8, 2021

As of February 8, 2021, Peter Drøidal is registered as adm. dir. of NOVARTIS HEALTHCARE A/S.

Judith Louise Love steps down as adm. dir. of NOVARTIS HEALTHCARE A/SFeb 8, 2021

As of February 8, 2021, Judith Louise Love has stepped down as adm. dir. of NOVARTIS HEALTHCARE A/S.

About NOVARTIS HEALTHCARE A/S

NOVARTIS HEALTHCARE A/S is a Danish company of the type Aktieselskab based in København S, founded in 1997. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Peter Drøidal. The company is owned by Novartis Pharma AG. The company has 125 employees.